Blue rubber bleb naevus syndrome

Overview

Blue rubber bleb naevus syndrome is a rare vascular malformation disorder that typically presents with characteristic skin lesions alongside internal vascular abnormalities. The condition derives its distinctive name from the appearance of the skin lesions, which resemble small blue rubber nipples and can be compressed like a rubber bulb, refilling slowly when pressure is released. These lesions represent venous malformations where blood vessels have formed abnormally.

The condition affects both males and females and usually becomes apparent during infancy or early childhood, though presentation can occasionally occur later in life. Exact prevalence is not well established, though the condition is rare. The syndrome primarily impacts quality of life through visible skin lesions, gastrointestinal bleeding complications, and the associated anaemia that often develops from chronic blood loss.

Symptoms & clinical features

The hallmark features are multiple soft, compressible, blue to purple skin lesions that vary considerably in size, from tiny spots to several centimetres in diameter. These vascular malformations typically feel rubbery to the touch and blanch partially with pressure before slowly refilling with blood. The number of lesions can range from a few to hundreds, and they may increase in number and size over time. Lesions commonly appear on the trunk and limbs but can develop anywhere on the body surface.

Internal manifestations most frequently involve the gastrointestinal tract, where similar vascular malformations develop in the lining of the stomach, small intestine, and colon. These internal lesions can bleed spontaneously, leading to symptoms including dark or bloody stools, abdominal pain, and progressive anaemia. Some individuals experience chronic low-grade bleeding that causes fatigue, weakness, and pallor due to iron deficiency. Less commonly, vascular malformations may develop in other organs including the liver, spleen, bladder, or central nervous system, though the gastrointestinal tract and skin remain the primary sites affected.

Video: Genetics 101

Affected organs

The skin and gastrointestinal tract are the organ systems most consistently affected in blue rubber bleb naevus syndrome. Cutaneous lesions represent the most visible manifestation and typically cause cosmetic concerns rather than functional impairment, though larger lesions may occasionally become painful or ulcerate if subjected to trauma.

The gastrointestinal involvement carries greater clinical significance due to the risk of bleeding. Vascular malformations can develop anywhere along the digestive tract from the oesophagus to the rectum, with the small intestine being particularly commonly affected. Bleeding from these lesions may be acute and severe or more typically chronic and intermittent, gradually depleting iron stores and causing persistent anaemia that requires ongoing management.

Multiple body systems

Systemic involvement

Cellular impact

Mechanism at cellular level

Risks & severity

The clinical spectrum varies considerably between affected individuals. Some people have predominantly skin lesions with minimal gastrointestinal involvement and experience few complications, whilst others develop extensive internal vascular malformations with significant bleeding risk. Gastrointestinal bleeding represents the most serious complication and typically emerges during childhood, though the age of onset and severity are unpredictable.

Chronic anaemia from ongoing blood loss is common and may require regular iron supplementation or periodic blood transfusions in more severely affected individuals. Life-threatening acute haemorrhage is uncommon but can occur. When vascular malformations develop in other organs, additional complications may arise depending on the site involved. Overall life expectancy is generally normal with appropriate monitoring and management, though quality of life may be significantly impacted by recurrent bleeding episodes and the need for ongoing medical intervention.

Genetic causes

Research suggests that blue rubber bleb naevus syndrome is caused by changes in TEK, which encodes a protein called TIE2 receptor tyrosine kinase. This receptor coordinates development and maintenance of blood vessel architecture by controlling how endothelial cells lining vessel walls communicate with surrounding pericytes.

When TEK carries pathogenic variants, the resulting protein cannot regulate vascular formation properly, and dilated malformed venous channels develop instead of normal vessels. The genetic alterations typically occur as somatic mosaic events, arising spontaneously in early embryonic stages rather than being inherited from either parent. Since only a proportion of the body's cells harbour the variant rather than every cell, the extent and location of vascular abnormalities depend on which developing tissues carried the altered gene.

• TEK
  TEK receptor tyrosine kinase

Inheritance pattern

Blue rubber bleb naevus syndrome typically occurs sporadically as a result of somatic mosaicism rather than following a traditional inheritance pattern. The TEK gene changes arise as new events during early development, affecting only a subset of the body's cells. This means the genetic variant is not present in the egg or sperm cells and therefore is not passed from parent to child.

Because the condition is not inherited in the typical sense, affected individuals generally do not have similarly affected parents, and the recurrence risk for future siblings is very low. Affected individuals themselves are unlikely to pass the condition to their children, as the genetic change is usually confined to somatic tissues rather than reproductive cells. Rare familial cases have been reported in medical literature, but the vast majority of cases represent isolated occurrences within a family.

Diagnosis & testing

Diagnosis of blue rubber bleb naevus syndrome is primarily clinical, based on the characteristic appearance of the skin lesions combined with evidence of gastrointestinal vascular malformations. The distinctive blue, compressible quality of the skin lesions is often sufficient to raise clinical suspicion, particularly when multiple lesions are present.

Confirmation typically involves endoscopic examination of the gastrointestinal tract to identify internal vascular malformations and assess bleeding risk. Imaging studies such as CT or MRI scanning may be employed to evaluate the extent of internal involvement. Genetic testing can identify pathogenic variants in TEK, supporting the clinical diagnosis, though the mosaic nature of the condition means that testing may not always detect the variant, particularly if blood samples are used and the variant is present at low levels. Referral to clinical genetics services through the NHS Genomic Medicine Service may be appropriate for genetic counselling and confirmation. Differential diagnosis includes other causes of multiple cutaneous vascular lesions and gastrointestinal bleeding.

Management & lifestyle

Management focuses on monitoring for complications and addressing bleeding when it occurs. Regular surveillance typically includes periodic blood tests to monitor haemoglobin levels and iron stores, along with endoscopic examination of the gastrointestinal tract to assess the extent of internal lesions and identify sites at high risk of bleeding.

Treatment approaches vary depending on symptom severity. Iron supplementation is commonly required to address anaemia from chronic blood loss. For problematic bleeding lesions, various interventional approaches may be considered, including endoscopic techniques, laser therapy, or surgical removal of severely affected bowel segments. Skin lesions generally do not require treatment unless they are painful, repeatedly traumatised, or causing significant cosmetic concern. NHS care typically involves coordination between gastroenterology, haematology, and where appropriate, interventional radiology or surgical teams. Patients and families should have access to genetic counselling through their local clinical genetics service to discuss the condition's implications and address questions about recurrence risks.

UK care pathway

Within the NHS Genomic Medicine Service, individuals with suspected blue rubber bleb naevus syndrome may be referred to clinical genetics services for assessment and genetic counselling. Whilst this is a rare condition, the characteristic clinical features often allow diagnosis without genetic testing, though TEK gene analysis may be pursued to confirm the underlying cause, particularly in atypical presentations.

Ongoing clinical management typically involves multidisciplinary input coordinated through specialist centres with expertise in vascular anomalies. Genetic counsellors can provide valuable support in helping families understand the sporadic nature of the condition and the low recurrence risk, as well as addressing questions about the implications for affected individuals and their future children.

Related conditions

Blue rubber bleb naevus syndrome should be distinguished from other conditions causing multiple vascular lesions. Hereditary haemorrhagic telangiectasia can cause gastrointestinal bleeding from vascular malformations but typically presents with recurrent nosebleeds and a clear autosomal dominant inheritance pattern. Multiple cutaneous and mucosal venous malformations syndrome shares overlapping features but is caused by variants in different genes and may show familial clustering.

Other conditions in the differential include diffuse cavernous haemangiomatosis, Maffucci syndrome (which combines vascular malformations with cartilage abnormalities), and Klippel-Trenaunay syndrome (which features vascular malformations alongside limb overgrowth). The distinctive appearance of the blue rubber bleb lesions and the pattern of primarily cutaneous and gastrointestinal involvement help distinguish this syndrome from these related disorders.

• Multiple cutaneous/mucosal venous malformation
  Vascular
  Shares 1 gene

Frequently asked questions

References

1. Ballieux F, Boon LM, Vikkula M. Blue bleb rubber nevus syndrome. Handbook of clinical neurology. 2015. PMID: 26564083
2. Wong XL, Phan K, Rodríguez Bandera AI. Sirolimus in blue rubber bleb naevus syndrome: A systematic review. Journal of paediatrics and child health. 2019. PMID: 30565378
3. Gupta N, Day AS. Editorial comment: blue rubber bleb naevus syndrome. Journal of paediatrics and child health. 2010. PMID: 20412196
4. Putra J, Kim GE. Diagnostic approach to hepatic vascular lesions: a paediatric perspective. Histopathology. 2024. PMID: 38924138
5. Crosher RF, Blackburn CW, Dinsdale RC. Blue rubber-bleb naevus syndrome. The British journal of oral & maxillofacial surgery. 1988. PMID: 3163496
6. Ishii T, Asuwa N, Suzuki S. Blue rubber bleb naevus syndrome. Virchows Archiv. A, Pathological anatomy and histopathology. 1988. PMID: 3144084
7. Wynford-Thomas R, Johnston A, Halpin S. Rarities in neurology: blue rubber bleb naevus syndrome. Practical neurology. 2014. PMID: 24614007
8. Shepherd V, Godbolt A, Casey T. Maffucci's syndrome with extensive gastrointestinal involvement. The Australasian journal of dermatology. 2005. PMID: 15670176